Direct antigen presentation through binding of donor intercellular adhesion molecule-1 to recipient lymphocyte function-associated antigen-1 molecules in xenograft rejection

Transplantation

Volumn 65, Issue 8, 1998, Pages 1094-1100

  Ohta, Yoshihiko ^a   Gotoh, Mitsukazu ^a,b   Ohzato, Hiroki ^a   Fukuzaki, Takayuki ^a   Nishihara, Masayoshi ^a   Dono, Keizo ^a   Umeshita, Koji ^a   Sakon, Masato ^a   Yagita, Hideo ^c   Okumura, Ko ^c   Tanaka, Toshiyuki ^a   Kawashima, Hiroto ^a   Miyasaka, Masayuki ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOPATHOGENESIS; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; T LYMPHOCYTE ACTIVATION; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; GRAFT REJECTION; GRAFT SURVIVAL; INTERCELLULAR ADHESION MOLECULE-1; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, WISTAR; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032571860     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199804270-00014     Document Type: Article

References (43)

1. Cavallo F, Martin-Fontecha A, Bellone M, et al. Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur J Immunol 1995; 25: 1154.
2. Wang YC, Zhu L, McHugh R, Sell KW, Selvaraj P. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice. Eur J Immunol 1995; 25: 1163.
3. Heemann UW, Tullius SG, Azuma H, Kupiec-Weglinsky J, Tilney NL. Adhesion molecules and transplantation. Ann Surg 1994; 219: 4.
4. Kuchroo VK, Prabhu Das M, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate deferentially the Th1/Th2 developmental pathway: application to autoimmune disease therapy. Cell 1995; 80: 707.
5. Archelos JJ, Maurer M, Jung S, Toyka KV, Hartung H-P. Suppression of experimental allergic neuritis by an antibody to the intracellular adhesion molecule ICAM-1. Brain 1993; 116: 1043.
6. Yagi N, Yokono K, Amano K, et al. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes. Diabetes 1995; 44: 744.
7. Herold KC, Vezys V, Gage A, Montag A. Prevention of autoimmune diabetes by treatment with anti-LFA-1 and anti-ICAM-1 monoclonal antibodies. Cell Immunol 1994; 157: 489.
8. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349.
9. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425.
10. Bluestone JA, Lechler RI. Transplantation. Curr Opin Immunol. 1995; 7: 617.
11. Stepkowski SM, Tu Y, Condon YP, Bennett CF. Blocking of heart allograft rejection by intercellular adhesion molecule-an anti-sense oligonucleotides alone or in combination with other immunosuppressive modalities. J Immunol 1994; 153: 5336.
12. Zeng Y, Gage A, Montag A, Rothlin R, Thistlethwaite JR, Bluestone JA. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies. Transplantation 1994; 58: 681.
13. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992; 255: 1125.
14. Kato Y, Yamataka A, Yagita H, Okumura K, Fujiwara T, Miyano T. Specific acceptance of fetal bowel allograft in mice after combined treatment with anti-intercellular adhesion molecule-1 and leucocyte function-associated antigen-1 antibodies. Ann Surg 1996; 223: 94.
15. Steurer W, Nickerson PW, Steele AW, Steiger J, Zheng XX, Strom TB. Ex vivo coating of islet cell allograft with murine CTLA4/Fc promotes graft tolerance. J Immunol 1995; 155: 1165.
16. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992; 257: 789.
17. Isobe M, Suzuki J, Yagita H, et al. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies. J Immunol 1994; 153: 5810
18. Qin L, Chavin KD, Lin J, Yagita H, Bromberg JS. Anti-CD2 receptor and anti-CD3 ligand (CD48) antibodies synergize to prolong allograft survival. J Exp Med 1994; 179: 341.
19. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
20. Kaufmann CL, Gaines BA, Ildstad H. Xenotransplantation. Annu Rev Immunol 1995; 13: 339.
21. Tamatani T, Kotani M, Miyasaka M. Characterization of the rat leucocyte integrin, CD11/CD18, by use of LFA-1 subunit-specific monoclonal antibodies. Eur J Immunol 1991; 21: 627.
22. Tamatani T, Miyasaka M. Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1 and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int Immunol 1990; 2: 165.
23. Yagita H, Nakamura T, Karasuyama H, Okumura K. Monoclonal antibodies specific for murine CD2 reveal its presence on B cells as well as T cells. Proc Natl Acad Sci USA 1989; 86: 645.
24. Nishimura T, Yagi H, Yagita H, Uchiyama Y, Hashimoto Y. Lymphocyte-activated cell-associated antigen involved in broad-reactive killer cell-mediated cytotoxicity. Cell Immunol 1987; 94: 122.
25. Iigo Y, Takashi T, Tamatani T, et al. ICAM-1-dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats. J Immunol 1991; 147: 4167.
26. Julius MH, Simpson E, Herzenberg LA. A rapid method for a isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 1973; 3: 645.
27. Makgoba MW, Sanders ME, Ginther-Luce GE, et al. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T, and myeloid cells. Nature 1988; 331: 86.
28. Rice GE, Munro JM, Bevilacqua MP, et al. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes: a CD11/CD18-independent adhesion mechanism. J Exp Med 1986; 171: 1369.
29. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation 1985; 40:437.
30. Gotoh M, Fukuzaki T, Monden M, et al. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation. Transplantation 1994; 57: 123
31. Nishihara M, Gotoh T, Ohzato H, et al. Awareness of donor alloantigens in anti-adhesion therapy induces antigen-specific unresponsiveness to islet allografts. Transplantation 1997; 64: 965.
32. Kita Y, Takashi T, Iigo Y, Tamatani T, Miyasaka M, Horiuchi T. Sequence and expression of rat ICAM-1. Biochim Biophys Acta 1992; 1131: 108.
33. Murray AG, Khodadoust MM, Pober JS, Bothwell ALM. Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1: 57.
34. Rollins SA, Kennedy SP, Chodera AJ, Elliott EA, Zavoico GB, Matis LA. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2. Transplantation 1994; 57: 1709.
35. Moses RD, Winn HJ, Auchincloss H Jr. Evidence that multiple defects in cell-surface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses. Transplantation 1992; 53: 209.
36. Campbell IL, Certri A, Wilkinson D, Boyd AW, Harrison LC. Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection. Proc Natl Acad Sci USA 1989; 86: 4282.
37. Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994; 84: 3261.
38. Gotoh M, Maki T, Porter J, Monaco AP. Augmented survival of purified islet xeno- and allografts with reduced numbers. Transplant Proc 1987; 19: 984.
39. Goss JA, Nakafusa Y, Finke EH, Flye MW, Lacy PE. Induction of tolerance to islet xenografts in a concordant rat-to-mouse model. Diabetes 1994; 43: 16.
40. Springer TA, Thompson WS, Miller LJ, Schmalstieg FC, Anderson DC. Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J Exp Med 1984; 160: 1901.
41. Kohl S, Loo LS, Schmalstieg FS, Anderson DC. The genetic deficiency of leucocyte surface glycoprotein Mac-1, LFA-1, p150,95 in human is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo. J Immunol 1986; 137: 1688.
42. Nakakura EK, Shorthouse RA, Zheng B, McCabe SM, Jardieu PM, Morris RE. Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy. Transplantation 1996; 62: 547.
43. Bashuda H, Takazawa K, Tamatani T, Miyasaka M, Yagita H, Okumura K. Inductiion of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intracellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506. Transplantation 1996; 62: 117.